Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria:: Technical and microbiological aspects

被引:71
作者
Foligné, B
Nutten, S
Steidler, L
Dennin, V
Goudercourt, D
Mercenier, A
Pot, B
机构
[1] Inst Pasteur, IBL Ecosyst, F-59019 Lille, France
[2] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland
[3] Univ Ghent, Dept Mol Biomed Res, B-9000 Ghent, Belgium
关键词
probiotics; TNBS mice model; standardization; strain evaluation; inflammatory bowel disease;
D O I
10.1007/s10620-006-3143-x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Probiotic bacteria have been shown to exert promising beneficial effects in different types of intestinal disorders, including chronic inflammation. In this context, animal models of inflammatory bowel disease are useful in studying the possible prophylactic role of candidate probiotic strains. This study aimed at evaluating the critical technological and microbiological parameters as well as the robustness of the murine trinitrobenzene sulfonic acid (TNBS)-induced model of colitis, after intragastric administration of lactic acid bacteria (LAB) preparations. A standardized methodology was applied to assess the protective effect achieved by various bacterial concentrations and culture conditions of the reference strain Lactobacithis plantarum. NCIMB 8826. Not only was protection found to vary in function in different levels of colitis, but also repeated experiments showed a clear bacterial dose-dependent attenuation of colitis. The physiological stage of bacteria was shown to impact as well, with substantial, mild, or reduced improvement of inflammatory scores for exponentially growing, stationary-phase, or killed bacteria, respectively. A recombinant strain, secreting murine interleukin-10 (IL-10) and previously reported to successfully treat colitis in two different models of murine colitis (dextran sulfate sodium [DSS] and IL-10-deficient mice), was used to validate the final experimental conditions. In conclusion, we identified and optimized some of the key parameters that need to be controlled in order to ensure reliable comparison of results generated over a long period of time or independent experiments. The recommendations for an improved model presented here will prove to be helpful for reproducible, independent comparison of the anti-inflammatory potential of wild-type or recombinant candidate probiotic strains, whether administered as pure cultures or as blends.
引用
收藏
页码:390 / 400
页数:11
相关论文
共 53 条
  • [1] Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis
    Ameho, CK
    Adjei, AA
    Harrison, EK
    Takeshita, K
    Morioka, T
    Arakaki, Y
    Ito, E
    Suzuki, I
    Kulkarni, AD
    Kawajiri, A
    Yamamoto, S
    [J]. GUT, 1997, 41 (04) : 487 - 493
  • [2] Campos F G, 1997, Rev Hosp Clin Fac Med Sao Paulo, V52, P180
  • [3] Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice
    Castagliuolo, I
    Galeazzi, F
    Ferrari, S
    Elli, M
    Brun, P
    Cavaggioni, A
    Tormen, D
    Sturniolo, GC
    Morelli, L
    Palù, G
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2005, 43 (02): : 197 - 204
  • [4] Properties of potential probiotic Lactobacillus plantarum strains
    Cebeci, A
    Gürakan, C
    [J]. FOOD MICROBIOLOGY, 2003, 20 (05) : 511 - 518
  • [5] Chandía O, 2003, J HIGH ENERGY PHYS
  • [6] The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats
    Cherbut, C
    Michel, C
    Lecannu, G
    [J]. JOURNAL OF NUTRITION, 2003, 133 (01) : 21 - 27
  • [7] Cong Yingzi, 2003, Current Drug Targets - Inflammation and Allergy, V2, P145, DOI 10.2174/1568010033484278
  • [8] Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2-/- mice upon transfer of CD4+CD45RBhi T cells
    Corazza, N
    Eichenberger, S
    Eugster, HP
    Mueller, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) : 1479 - 1491
  • [9] Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (BPARγ) heterodimer:: A basis for new therapeutic strategies
    Desreumaux, P
    Dubuquoy, L
    Nutten, S
    Peuchmaur, M
    Englaro, W
    Schoonjans, K
    Derijard, B
    Desvergne, B
    Wahli, W
    Chambon, P
    Leibowitz, MD
    Colombel, JF
    Auwerx, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (07) : 827 - 838
  • [10] Dunne C, 2001, AM J CLIN NUTR, V73, p386S, DOI 10.1093/ajcn/73.2.386s